Harte Group Expands Global Network to Support Pharmaceutical Companies
Doylestown, Pa.
Harte Group, a global company who manages and represents Functional Service Providers for support of clinical development needs, announced that its growing network of partners has reached 44 companies, employing over 7,900 experienced staff with an average company life of 13 years in business.
Due to a changing landscape within clinical development operations and the market being underserved by the existing full-service CRO model, the Harte Group created a full-service CRO offering - one built by leveraging smaller companies. Many sponsors have been looking for alternatives to support smaller programs in their portfolio, as well as looking for more ways to execute their clinical programs and projects.
"I am excited by the high level of interest in this Functional Services Provider model," said Michael Harte, Founder & President of the Harte Group. Harte mentioned that their team is in active discussions with both large pharma and smaller biotechnology firms.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
